Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
REDWOOD CITY, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq:LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference in New York on Wednesday, November 29, 2023, at 11:00 AM PT / 2:00 PM ET.
Related news for (LUNG)
- Pulmonx Reports First Quarter 2025 Financial Results
- Don’t Miss Out: MoBot’s Latest Stock Updates 02/20/25 11:00 AM
- Today’s Top Performers: MoBot’s Market Review 02/20/25 10:00 AM
- Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results
- 24/7 Market News Snapshot 19 February, 2025 – Pulmonx Corporation Common Stock (NASDAQ:LUNG)